Pages that link to "Q34693888"
Jump to navigation
Jump to search
The following pages link to The deficiency of Akt1 is sufficient to suppress tumor development in Pten /- mice (Q34693888):
Displayed 50 items.
- Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity (Q24316318) (← links)
- mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice (Q24658113) (← links)
- The PI3K/Akt Pathway in Tumors of Endocrine Tissues (Q26770404) (← links)
- Genetically engineered mouse models of prostate cancer (Q27026768) (← links)
- Therapeutic targeting of cancers with loss of PTEN function (Q27852764) (← links)
- A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth (Q28116222) (← links)
- Role of PI3K, mTOR and Akt2 signalling in hepatic tumorigenesis via the control of PKM2 expression (Q28294651) (← links)
- Poly(ester amine)-mediated, aerosol-delivered Akt1 small interfering RNA suppresses lung tumorigenesis (Q28384723) (← links)
- Id4 deficiency attenuates prostate development and promotes PIN-like lesions by regulating androgen receptor activity and expression of NKX3.1 and PTEN (Q28592943) (← links)
- Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases (Q29248612) (← links)
- Targeting the phosphoinositide 3-kinase pathway in cancer (Q29615809) (← links)
- Molecular cues on obesity signals, tumor markers and endometrial cancer. (Q30372789) (← links)
- Activation of Akt signaling in prostate induces a TGFβ-mediated restraint on cancer progression and metastasis (Q30408632) (← links)
- Akt-dependent regulation of NF-{kappa}B is controlled by mTOR and Raptor in association with IKK. (Q30440717) (← links)
- Genetic profiling to determine risk of relapse-free survival in high-risk localized prostate cancer. (Q30573750) (← links)
- RFP-mediated ubiquitination of PTEN modulates its effect on AKT activation (Q32884571) (← links)
- PTEN is a tumor suppressor in CML stem cells and BCR-ABL-induced leukemias in mice (Q33608760) (← links)
- Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice (Q33667276) (← links)
- Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways (Q33737298) (← links)
- The PI3K-Akt-mTOR pathway in initiation and progression of thyroid tumors (Q33770769) (← links)
- Progesterone: the ultimate endometrial tumor suppressor. (Q33773307) (← links)
- Subcellular localization of activated AKT in estrogen receptor- and progesterone receptor-expressing breast cancers: potential clinical implications (Q33816285) (← links)
- Loss of CDH1 and Pten accelerates cellular invasiveness and angiogenesis in the mouse uterus. (Q33826091) (← links)
- Novel inhibitors of AKT: assessment of a different approach targeting the pleckstrin homology domain (Q33882138) (← links)
- A novel three-dimensional culture system of polarized epithelial cells to study endometrial carcinogenesis. (Q33882422) (← links)
- Inhibition of Akt with small molecules and biologics: historical perspective and current status of the patent landscape (Q33920097) (← links)
- PTEN-deficient tumors depend on AKT2 for maintenance and survival (Q34016861) (← links)
- Artemin Reduces Sensitivity to Doxorubicin and Paclitaxel in Endometrial Carcinoma Cells through Specific Regulation of CD24. (Q34041350) (← links)
- Inhibition of phosphatidylinositol 3-kinase/Akt signaling suppresses tumor cell proliferation and neuroendocrine marker expression in GI carcinoid tumors (Q34048712) (← links)
- Akt1 deletion prevents lung tumorigenesis by mutant K-ras (Q34049042) (← links)
- The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer (Q34091442) (← links)
- Molecular genetics of prostate cancer: new prospects for old challenges (Q34127462) (← links)
- Mouse models of endocrine tumours. (Q34129129) (← links)
- MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme (Q34262423) (← links)
- mTOR pathway is activated by PKA in adrenocortical cells and participates in vivo to apoptosis resistance in primary pigmented nodular adrenocortical disease (PPNAD). (Q34285768) (← links)
- An allosteric Akt inhibitor effectively blocks Akt signaling and tumor growth with only transient effects on glucose and insulin levels in vivo (Q34329614) (← links)
- Reduction of Pten dose leads to neoplastic development in multiple organs of Pten (shRNA) mice (Q34479331) (← links)
- Interrogating two schedules of the AKT inhibitor MK-2206 in patients with advanced solid tumors incorporating novel pharmacodynamic and functional imaging biomarkers (Q34518245) (← links)
- Receptor-recognized α₂-macroglobulin binds to cell surface-associated GRP78 and activates mTORC1 and mTORC2 signaling in prostate cancer cells (Q34525572) (← links)
- Requirement for ribosomal protein S6 kinase 1 to mediate glycolysis and apoptosis resistance induced by Pten deficiency (Q34572866) (← links)
- TSC2 deficiency increases PTEN via HIF1alpha (Q34658958) (← links)
- Evidence for a pro-proliferative feedback loop in prostate cancer: the role of Epac1 and COX-2-dependent pathways (Q34707066) (← links)
- Regulation of Akt signaling activation by ubiquitination (Q34799443) (← links)
- Adenovirus mediated homozygous endometrial epithelial Pten deletion results in aggressive endometrial carcinoma (Q35011872) (← links)
- Targeting the Akt/mTOR pathway in Brca1-deficient cancers (Q35023287) (← links)
- Deficiency of Akt1, but not Akt2, attenuates the development of pulmonary hypertension (Q35115837) (← links)
- Opposing functions of Akt isoforms in lung tumor initiation and progression (Q35145125) (← links)
- Akt1 deficiency delays tumor progression, vascular invasion, and distant metastasis in a murine model of thyroid cancer (Q35151491) (← links)
- Role of Pten in leukemia stem cells (Q35169570) (← links)
- Hexokinase 2-mediated Warburg effect is required for PTEN- and p53-deficiency-driven prostate cancer growth (Q35180333) (← links)